Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - TOTAL DEBT REPAID
Total Debt Repaid PRPH - ProPhase Labs, Inc.
10.5 M
LAST VALUE
1435.80%
2 YEAR CAGR
0.00%
5 YEAR CAGR
59.60%
10 YEAR CAGR